Introduction
A lymphoma-like syndrome, both clinical and pathological, induced by anti-convulsant drugs, especially of the hydantoin group, has been described (Saltzstein and Ackerman, 1959 ). Hodgkin's disease and malignant lymphoma developing during anticonvulsant therapy has also been recorded (Hyman and Sommers, 1966) . We wish to report a patient who developed a lymphoma-like syndrome following para-aminosalicylic acid.
Case report
A 40-year-old male was seen in May 1976 at a local hospital, with fever and chest pain. Examination revealed a left-sided pleural effusion which on aspiration yielded 500 ml of straw-coloured fluid. He was treated with penicillin for 10 days with no benefit. He was then administered standard antituberculous drugs--streptomycin, isoniazid and para-aminosalicylic acid (PAS). Two weeks later, the patient developed high fever with chills followed by a generalized erythematous rash and generalized lymphadenopathy. He was then transferred to our unit, and examination revealed a febrile patient with generalized lymphadenopathy, hepatomegaly and an erythematous rash. The spleen was not palpable and he was not jaundiced. The lymph nodes were large (2-3 cm), discrete, rubbery and non-tender. The lungs were clear.
Laboratory investigations
The total white cell count was 14x 109/litre with 38% eosinophils. The The anti-tuberculous drugs were discontinued on the day of admission. The patient became afebrile the following day and the rash subsided over the next 4-5 days. The liver and the lymph nodes receded gradually over 2 weeks and were minimal at the end of this period when the patient was discharged from our unit. He was regularly followed up and 5 years later remains in good health with no recurrence of the lymphadenopathy. The white cell count was normal.
Discussion
Lymphadenopathy, hepatomegaly and eosinophilia associated with fever and a scarlatiniform or morbilliform rash are recorded manifestations of PAS sensitivity. The disorder resolves in a few weeks after the drug is withdrawn. Our patient remains well 5 years after the onset of his illness,' with no recurrence of his lymphadenopathy. Whether he will eventually develop a lymphoma is a moot point.
Angio-immunoblastic lymphadenopathy, recently described by Frizzera, Moran and Rappaport (1974) has features that are similar to PAS sensitivity being associated frequently with either polyclonal gammo- 
